Skip to content
← Back to this collection

PUBLICATIONS · 22521551

Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leuk Res
Publication date
2012 Jul
First author
Barbany G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Barbany G
      type
      Author
    2. name
      Andersen MK
      type
      Author
    3. name
      Autio K
      type
      Author
    4. name
      Borgström G
      type
      Author
    5. name
      Franco LC
      type
      Author
    6. name
      Golovleva I
      type
      Author
    7. name
      Heim S
      type
      Author
    8. name
      Heinonen K
      type
      Author
    9. name
      Hovland R
      type
      Author
    10. name
      Johansson B
      type
      Author
    11. name
      Johannsson JH
      type
      Author
    12. name
      Kjeldsen E
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Barbany G
      type
      Author
    2. name
      Andersen MK
      type
      Author
    3. name
      Autio K
      type
      Author
    4. name
      Borgström G
      type
      Author
    5. name
      Franco LC
      type
      Author
    6. name
      Golovleva I
      type
      Author
    7. name
      Heim S
      type
      Author
    8. name
      Heinonen K
      type
      Author
    9. name
      Hovland R
      type
      Author
    10. name
      Johansson B
      type
      Author
    11. name
      Johannsson JH
      type
      Author
    12. name
      Kjeldsen E
      type
      Author
    bibliography ids
    1. nci-bib-909bb78f9a659f030134d4df
    book metadata
    content sha256
    58316f1399cf606a62de912f890a81db885727e858b55ceebcfa2026d47ff5c5
    document type
    citation
    dois
    1. 10.1016/j.leukres.2012.03.024
    electronic publication date
    display
    2012 Apr 21
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22521551
    immutable id
    pubmed:22521551@58316f1399cf606a62de912f890a81db885727e858b55ceebcfa2026d47ff5c5
    journal
    abbreviation
    Leuk Res
    issn electronic
    1873-5835
    issn print
    0145-2126
    issue
    7
    name
    Leukemia research
    nlm unique id
    7706787
    pages
    936-8
    volume
    36
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22521551
      provenance
      batch id
      c95be1d0b8cf19942816
      provider
      NCBI PubMed ESummary
      record sha256
      191263dbf2375d641e626b3c312c7d86d615609b9b6afaf804f88eebaa91a11b
      response sha256
      a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
      retrieved at
      2026-09-09T23:46:47.691937+00:00
      publication date
      display
      2012 Jul
      precision
      month
      year
      2012
      publication types
      1. Letter
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22521551/
      title
      Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.

      Preserved source evidence · Independent clinical review pending · Not medical advice